Literature DB >> 9550468

Synergistic effect between IL-10 and bcl-2 genotypes in determining susceptibility to systemic lupus erythematosus.

R Mehrian1, F P Quismorio, G Strassmann, M M Stimmler, D A Horwitz, R C Kitridou, W J Gauderman, J Morrison, C Brautbar, C O Jacob.   

Abstract

OBJECTIVE: To determine whether genes participating in programmed cell death, including bcl-2, IL-10, Fas-L, and CTLA-4, may contribute to the genetic predisposition to systemic lupus erythematosus (SLE).
METHODS: First, intragenic markers for the bcl-2, IL-10, Fas-L, and CTLA-4 genes were characterized and their extent of polymorphism in normal populations was determined. The allelic distribution of these gene markers in a large Mexican American SLE cohort of 158 patients and 223 ethnically matched controls was determined using fluorescent-labeled primers and semiautomated genotyping.
RESULTS: The bcl-2, Fas-L, and IL-10 loci showed significantly different allelic distribution in SLE patients compared with controls, indicating an association between these genes and SLE. No association was found between SLE and the CTLA-4 gene. Further analysis revealed a synergistic effect between susceptibility alleles of the bcl-2 and IL-10 genes in determining disease susceptibility. Alone, the presence of each of these alleles was associated with a moderate increase in SLE risk, while the occurrence of these alleles together increased the odds of developing SLE by more than 40-fold.
CONCLUSION: The results suggest that individuals carrying specific genotypes of both bcl-2 and IL-10 are at significant risk of developing SLE.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9550468     DOI: 10.1002/1529-0131(199804)41:4<596::AID-ART6>3.0.CO;2-2

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  37 in total

Review 1.  Cytokines and systemic lupus erythematosus.

Authors:  G S Dean; J Tyrrell-Price; E Crawley; D A Isenberg
Journal:  Ann Rheum Dis       Date:  2000-04       Impact factor: 19.103

2.  Quantitative trait loci on chromosomes 1, 2, 3, 4, 8, 9, 11, 12, and 18 control variation in levels of T and B lymphocyte subpopulations.

Authors:  M A Hall; P J Norman; B Thiel; H Tiwari; A Peiffer; R W Vaughan; S Prescott; M Leppert; N J Schork; J S Lanchbury
Journal:  Am J Hum Genet       Date:  2002-04-09       Impact factor: 11.025

Review 3.  Genetics and systemic lupus erythematosus.

Authors:  B P Tsao; J M Grossman
Journal:  Curr Rheumatol Rep       Date:  2001-06       Impact factor: 4.592

Review 4.  Biomarkers in systemic lupus erythematosus.

Authors:  Gabor G Illei; Peter E Lipsky
Journal:  Curr Rheumatol Rep       Date:  2004-10       Impact factor: 4.592

5.  Association of apoptosis-related microsatellite polymorphisms on chromosome 1q in Taiwanese systemic lupus erythematosus patients.

Authors:  J-Y Chen; C-M Wang; S-C Lu; Y-H Chou; S-F Luo
Journal:  Clin Exp Immunol       Date:  2006-02       Impact factor: 4.330

Review 6.  An update on genetic studies of systemic lupus erythematosus.

Authors:  Betty P Tsao
Journal:  Curr Rheumatol Rep       Date:  2002-08       Impact factor: 4.592

7.  Identification of new SLE-associated genes with a two-step Bayesian study design.

Authors:  D L Armstrong; A Reiff; B L Myones; F P Quismorio; M Klein-Gitelman; D McCurdy; L Wagner-Weiner; E Silverman; J O Ojwang; K M Kaufman; J A Kelly; J T Merrill; J B Harley; S-C Bae; T J Vyse; G S Gilkeson; P M Gaffney; K L Moser; C Putterman; J C Edberg; E E Brown; J Ziegler; C D Langefeld; R Zidovetzki; C O Jacob
Journal:  Genes Immun       Date:  2009-05-14       Impact factor: 2.676

Review 8.  IL-10 and TNFalpha genotypes in SLE.

Authors:  Patricia López; Carmen Gutiérrez; Ana Suárez
Journal:  J Biomed Biotechnol       Date:  2010-06-21

Review 9.  The role of apoptosis proteins and complement components in the etiopathogenesis of systemic lupus erythematosus.

Authors:  Bernadete L Liphaus; Maria Helena Bittencourt Kiss
Journal:  Clinics (Sao Paulo)       Date:  2010-03       Impact factor: 2.365

10.  Overexpression and secretion of the soluble CTLA-4 splice variant in various autoimmune diseases and in cases with overlapping autoimmunity.

Authors:  Suad AlFadhli
Journal:  Genet Test Mol Biomarkers       Date:  2013-02-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.